Anti-TACE / ADAM17 Antibody

• Description:

  Rabbit Polyclonal Antibody specific to TACE (CT)

• Product Name Alternative:

  ADAM 17, EC 3.4.24.86, Snake venom-like protease, TNF-α convertase, TNF-α-converting enzyme, CD antigen CD156b

• Gene Name:

  ADAM17

• Gene ID:

  6868

• NCBI Gene ID:

  ADAM17

• UniProt:

  P78536

• Accession Number:

  NP_003174

• Cellular Locus:

  Membrane; Single-pass type I membrane protein.

• Host:

  Rabbit

• Reactivity:

  Human, Mouse, Rat

• Immunogen:

  Peptide corresponding to aa 807-823 of human TACE (accession no. NP_003174). This sequence differs from mouse and rat TACE by one amino acid.

• Target Antigen:

  Disintegrin and metalloproteinase domain-containing protein 17

• Target:

  TACE / ADAM17

• Clonality:

  Polyclonal

• Isotype:

  IgG

• Type:

  Antibody

• Applications:

  ELISA, WB, ICC, IF

• Field of Research:

  Apoptosis

• Purification Method:

  Purified by peptide immuno-affinity chromatography

• Concentration:

  Lot Specific

• Dilution:

  Dilute in PBS or medium which is identical to that used in the assay system.

• Format:

  Purified

• Form:

  Liquid

• Buffer:

  Phosphate Buffered Saline

• Function:

  Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form (PubMed:9034191). Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (PubMed:20592283). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed:12441351). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) (PubMed:24226769). Plays a role in the proteolytic processing of ACE2 (PubMed:24227843). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (By similarity). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (PubMed:26876177, PubMed:28060820). Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells. {UniProtKB:Q9Z0F8, PubMed:12441351, PubMed:20592283, PubMed:24226769, PubMed:24227843, PubMed:24337742, PubMed:26876177, PubMed:28060820, PubMed:9034191}.

• Additionnal Information:

  Immunoblotting: use at 1ug/mL.
  
  Positive control: HeLa or Jurkat cell lysate.
  
  Immunocytochemistry: use at 10ug/mL.
  
  These are recommended concentrations.
  
  Enduser should determine optimal concentrations for their applications.

• Storage Conditions:

  This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze-thaw cycles.

• Specificity:

  This antibody recognizes human, mouse, and rat TACE, and 80-130kDa bands are detected in immunoblots. These bands may represent mature protein, precursor, and glycosylated TACE.

• Formulation:

  PBS, pH 7.4.

• Buffer pH:

  pH 7.4

• Target Background:

  TNFalpha is synthesized as a 26kDa type II membrane-bound precursor that is cleaved by a convertase to generate secreted 17kDa mature TNFalpha. TNFalpha converting enzyme (TACE) has been identified, and human and mouse TACE cDNAs have been cloned. TACE is a membrane-bound metalloprotease-disintegrin in the family of mammalian ADAM (for a disintegrin and metalloprotease). TACE also processes other cell surface proteins, including TNF receptor, TGFalpha, L-selectin, and alpha-cleavage of amyloid protein precursor (APP). TACE mRNA is expressed in a variety of human and mouse tissues.

• CAS Number:

  9007-83-4